COVID-19 has long-term effects on the lungs: While the lungs can recover from severe COVID-19 disease, they can sustain long term damage by leaving a scar behind The SARS-CoV-2 virus enters the cells of the airway through angiotensin-converting enzyme reporter, a molecule that connects the inside of our cells to the outside via the cell membrane. When this happens, an intense immune response, known as cytokine storm occurs, along with increased blood clotting, all of which leads to damage of lung cells. The body replaces the cells damaged by the virus with scar tissue, which is thick and rigid. This can result in a condition called ‘pulmonary fibrosis’, which is mostly seen in people diagnosed with COVID-19. This condition is probably more likely to develop if the lungs are severely affected by the infection. The condition can make people experience breathlessness while doing routine activities. Anyone can have mild to severe symptoms from COVID-19. There are some individuals who are at higher risk for severe illness. Based on current information:

· Risk increases as you age so the older you are, the higher your risk.

 · People of all ages with underlying medical conditions, including:  People with chronic obstructive pulmonary disease (COPD).  People who are immune compromised from solid organ transplantation.

 · People with severe obesity (Body Mass Index of 30 or higher)

· Other medical conditions including serious heart conditions, type 2 diabetes, Sickle cell disease and people with chronic kidney disease

Submit manuscripts through online link: https://www.longdom.org/submissions/clinical-research-bioethics.html or as an attachment to below Email Id

Eliza Grace
Managing Editor
Journal of Clinical Research and Bioethics
Email: bioethics@eclinicalsci.com
What’s App : +1-947-333-440